Literature DB >> 7926345

Evidence of higher insulin resistance in NIDDM patients with ischaemic heart disease.

S Inchiostro1, G Bertoli, G Zanette, V Donadon.   

Abstract

Prospective studies have shown a relationship between hyperinsulinaemia, an indirect index of insulin resistance, and IHD in men with normal glucose tolerance. In NIDDM this association is less clear possibly due to the poor significance of insulin and C-peptide concentrations as an index of insulin resistance. Therefore, only a direct measurement of insulin sensitivity could clarify the possible relationship between insulin resistance and IHD in NIDDM. We have evaluated insulin sensitivity, by means of an ITT, and some risk factors for IHD in 72 men with NIDDM, 36 with and 36 without IHD, attending our out-patient Diabetic Clinic. The two groups were of similar age, duration of diabetes, glycaemic control and body composition. Subjects with IHD were more insulin resistant (K(ITT) index 2.45 +/- 0.18 vs 3.12 +/- 0.13% per min, in patients with and without IHD, respectively, p < 0.004), had higher total (p = 0.011) and LDL serum cholesterol levels (p = 0.010) and greater prevalence of hypertension (p = 0.001) compared to subjects without IHD. Using step-wise logistic regression analysis, insulin resistance (odds ratio 2.57, 95% CI 1.87-3.28, p = 0.008), hypertension (odds ratio 8.17, 95% CI 6.86-9.48, p = 0.002), total serum cholesterol levels (odds ratio 1.02, 95% CI 1.005-1.035, p = 0.015) and BMI (0.79, 95% CI 0.67-0.97, p = 0.049) were independently associated with IHD. After adjustment for age and duration of diabetes, only insulin sensitivity was directly related to the age of onset of IHD, independently from other clinical and metabolic parameters (p < 0.015).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926345     DOI: 10.1007/bf00403379

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  48 in total

1.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

2.  Prediction of lean body mass from height and weight.

Authors:  R Hume
Journal:  J Clin Pathol       Date:  1966-07       Impact factor: 3.411

3.  Intravenous glucose tolerance and mortality in non-insulin-dependent diabetes mellitus.

Authors:  S W Coppack; H A Doll; B Pim; T D Hockaday
Journal:  Q J Med       Date:  1990-05

4.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.

Authors:  B C Martin; J H Warram; A S Krolewski; R N Bergman; J S Soeldner; C R Kahn
Journal:  Lancet       Date:  1992-10-17       Impact factor: 79.321

5.  The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics.

Authors:  R J Jarrett; P McCartney; H Keen
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

6.  The relationship of acute insulin sensitivity to the progression of vascular disease in long-term type 1 (insulin-dependent) diabetes mellitus.

Authors:  F I Martin; J L Hopper
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

7.  Glucose tolerance and insulin response to glucose in nondiabetic young male survivors of myocardial infarction.

Authors:  A Hamsten; S Eféndic; G Walldius; A Szamosi; U de Faire
Journal:  Am Heart J       Date:  1987-04       Impact factor: 4.749

8.  Daily insulin dose as a predictor of macrovascular disease in insulin treated non-insulin-dependent diabetics.

Authors:  H U Janka; A G Ziegler; E Standl; H Mehnert
Journal:  Diabete Metab       Date:  1987-07

9.  Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up.

Authors:  A Fontbonne; M A Charles; N Thibult; J L Richard; J R Claude; J M Warnet; G E Rosselin; E Eschwège
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

10.  Hyperinsulinaemia is associated with development of electrocardiographic abnormalities in diabetics.

Authors:  R M Hillson; T D Hockaday; J I Mann; D J Newton
Journal:  Diabetes Res       Date:  1984-09
View more
  6 in total

1.  Evolution of insulin resistance in coronary artery disease patients on four different pharmacological therapies.

Authors:  G Piédrola; E Novo; J Serrano-Gotarredona; M L de Teresa; R García-Robles
Journal:  Postgrad Med J       Date:  1999-01       Impact factor: 2.401

2.  Surrogate markers of insulin resistance: A review.

Authors:  Bhawna Singh; Alpana Saxena
Journal:  World J Diabetes       Date:  2010-05-15

3.  Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin.

Authors:  Valter Donadon; Massimiliano Balbi; Pietro Casarin; Alessandro Vario; Alfredo Alberti
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

4.  Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease.

Authors:  S G Wannamethee; G D O Lowe; A G Shaper; A Rumley; L Lennon; P H Whincup
Journal:  Diabetologia       Date:  2004-09-09       Impact factor: 10.122

5.  Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease.

Authors:  Valter Donadon; Massimiliano Balbi; Michela Ghersetti; Silvia Grazioli; Antonio Perciaccante; Giovanni Della Valentina; Rita Gardenal; Maria Dal Mas; Pietro Casarin; Giorgio Zanette; Cesare Miranda
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

Review 6.  Diabetes Mellitus and Risk of Hepatocellular Carcinoma.

Authors:  Xu Li; Xiaocong Wang; Pujun Gao
Journal:  Biomed Res Int       Date:  2017-12-12       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.